Cizzle Biotech

Cizzle Biotech Focuses on Early Lung Cancer Detection by Developing Immunoassay Tests for the CIZ1 B Biomarker. The core technology of Cizzle Biotech has been patented and a laboratory test has been developed, which has been used to validate the detection of lung cancer using the CIZ1 B biomarker.